Alembic has reported results for third quarter ended December 31, 2021.
The company has reported fall of 12.22% in its net profit at Rs 3.95 crore for the quarter under review as compared to Rs 4.50 crore for the same quarter in the previous year. However, total income of the company increased by 21.16% at Rs 20.50 crore for Q3FY22 as compared Rs 16.92 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported fall of 15.40% in its net profit at Rs 4.12 crore for the quarter under review as compared to Rs 4.87 crore for the same quarter in the previous year. However, total income of the company increased by 20.34% at Rs 21.06 crore for Q3FY22 as compared Rs 17.50 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |